ERBB2 and fibrosarcoma: The same effectors remained without any effect when SCID mice were inoculated with the HER-2/neu+ HLA-A2.1− tumour lines SKBR3 or SKOV3 or with the murine MC57X fibrosarcoma (Figure 3C–E), demonstrating the specificity of the in vivo responses.